• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统分析剪接变异特征揭示了肾透明细胞癌的预后预测因子。

Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.

机构信息

School Of Medicine, Guizhou University, Guiyang, Guizhou, China.

Department of Oral and Maxillofacial Surgery, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.

出版信息

J Cell Physiol. 2019 Dec;234(12):22753-22764. doi: 10.1002/jcp.28840. Epub 2019 May 29.

DOI:10.1002/jcp.28840
PMID:31140607
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6771988/
Abstract

There is growing evidence that alternative splicing (AS) plays an important role in cancer development. However, a comprehensive analysis of AS signatures in kidney renal clear cell carcinoma (KIRC) is lacking and urgently needed. It remains unclear whether AS acts as diagnostic biomarkers in predicting the prognosis of KIRC patients. In the work, gene expression and clinical data of KIRC were obtained from The Cancer Genome Atlas (TCGA), and profiles of AS events were downloaded from the SpliceSeq database. The RNA sequence/AS data and clinical information were integrated, and we conducted the Cox regression analysis to screen survival-related AS events and messenger RNAs (mRNAs). Correlation between prognostic AS events and gene expression were analyzed using the Pearson correlation coefficient. Protein-protein interaction analysis was conducted for the prognostic AS-related genes, and a potential regulatory network was built using Cytoscape (version 3.6.1). Meanwhile, functional enrichment analysis was conducted. A prognostic risk score model is then established based on seven hub genes (KRT222, LENG8, APOB, SLC3A1, SCD5, AQP1, and ADRA1A) that have high performance in the risk classification of KIRC patients. A total 46,415 AS events including 10,601 genes in 537 patients with KIRC were identified. In univariate Cox regression analysis, 13,362 survival associated AS events and 8,694 survival-specific mRNAs were detected. Common 3,105 genes were screen by overlapping 13,362 survival associated AS events and 8,694 survival-specific mRNAs. The Pearson correlation analysis suggested that 13 genes were significantly correlated with AS events (Pearson correlation coefficient >0.8 or <-0.8). Then, We conducted multivariate Cox regression analyses to select the potential prognostic AS genes. Seven genes were identified to be significantly related to OS. A prognostic model based on seven genes was constructed. The area under the ROC curve was 0.767. In the current study, a robust prognostic prediction model was constructed for KIRC patients, and the findings revealed that the AS events could act as potential prognostic biomarkers for KIRC.

摘要

越来越多的证据表明,可变剪接(AS)在癌症发展中起着重要作用。然而,目前缺乏对肾透明细胞癌(KIRC)中 AS 特征的全面分析,这是非常有必要的。目前尚不清楚 AS 是否可以作为诊断生物标志物来预测 KIRC 患者的预后。在这项工作中,从癌症基因组图谱(TCGA)中获取了 KIRC 的基因表达和临床数据,并从 SpliceSeq 数据库中下载了 AS 事件的图谱。整合了 RNA 序列/AS 数据和临床信息,我们通过 Cox 回归分析筛选与生存相关的 AS 事件和信使 RNA(mRNA)。使用 Pearson 相关系数分析了预后 AS 事件与基因表达之间的相关性。对预后 AS 相关基因进行蛋白质-蛋白质相互作用分析,并使用 Cytoscape(版本 3.6.1)构建潜在的调控网络。同时,进行了功能富集分析。然后,基于在 KIRC 患者风险分类中表现出高性能的七个关键基因(KRT222、LENG8、APOB、SLC3A1、SCD5、AQP1 和 ADRA1A)建立了一个预后风险评分模型。在 537 名 KIRC 患者中,共鉴定出 46415 个包括 10601 个基因的 AS 事件。在单变量 Cox 回归分析中,检测到 13362 个与生存相关的 AS 事件和 8694 个与生存特异性 mRNAs。通过重叠 13362 个与生存相关的 AS 事件和 8694 个与生存特异性 mRNAs,筛选出 1305 个常见基因。通过 Pearson 相关分析,发现 13 个基因与 AS 事件显著相关(Pearson 相关系数>0.8 或<-0.8)。然后,我们进行了多变量 Cox 回归分析,以选择潜在的预后 AS 基因。确定了七个与 OS 显著相关的基因。基于七个基因构建了一个预后模型。ROC 曲线下面积为 0.767。在本研究中,为 KIRC 患者构建了一个稳健的预后预测模型,研究结果表明,AS 事件可以作为 KIRC 的潜在预后生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df8/6771988/103e3a858f03/JCP-234-22753-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df8/6771988/56191ff323c6/JCP-234-22753-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df8/6771988/cda2162faa88/JCP-234-22753-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df8/6771988/61e45b8b7666/JCP-234-22753-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df8/6771988/5b88efd60c23/JCP-234-22753-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df8/6771988/43776602aed7/JCP-234-22753-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df8/6771988/4014d1e15ccd/JCP-234-22753-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df8/6771988/347a754ebda4/JCP-234-22753-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df8/6771988/9cc4583a4d40/JCP-234-22753-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df8/6771988/d69f492daad9/JCP-234-22753-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df8/6771988/103e3a858f03/JCP-234-22753-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df8/6771988/56191ff323c6/JCP-234-22753-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df8/6771988/cda2162faa88/JCP-234-22753-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df8/6771988/61e45b8b7666/JCP-234-22753-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df8/6771988/5b88efd60c23/JCP-234-22753-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df8/6771988/43776602aed7/JCP-234-22753-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df8/6771988/4014d1e15ccd/JCP-234-22753-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df8/6771988/347a754ebda4/JCP-234-22753-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df8/6771988/9cc4583a4d40/JCP-234-22753-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df8/6771988/d69f492daad9/JCP-234-22753-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7df8/6771988/103e3a858f03/JCP-234-22753-g010.jpg

相似文献

1
Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.系统分析剪接变异特征揭示了肾透明细胞癌的预后预测因子。
J Cell Physiol. 2019 Dec;234(12):22753-22764. doi: 10.1002/jcp.28840. Epub 2019 May 29.
2
Systematic analysis of survival-associated alternative splicing signatures in clear cell renal cell carcinoma.系统分析透明细胞肾细胞癌中与生存相关的可变剪接特征。
J Cell Biochem. 2020 Oct;121(10):4074-4084. doi: 10.1002/jcb.29590. Epub 2019 Dec 30.
3
Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.构建并验证自噬相关长非编码 RNA 标志物用于预测肾透明细胞癌患者的预后
Cancer Med. 2021 Apr;10(7):2359-2369. doi: 10.1002/cam4.3820. Epub 2021 Mar 2.
4
Landscape analysis of alternative splicing in kidney renal clear cell carcinoma and their clinical significance.肾脏透明细胞癌中可变剪接的景观分析及其临床意义。
Aging (Albany NY). 2024 Jun 10;16(11):10016-10032. doi: 10.18632/aging.205915.
5
Systematic Identification of Survival-Associated Alternative Splicing Events in Kidney Renal Clear Cell Carcinoma.系统鉴定肾透明细胞癌中与生存相关的可变剪接事件。
Comput Math Methods Med. 2021 Apr 19;2021:5576933. doi: 10.1155/2021/5576933. eCollection 2021.
6
Alternative splicing associated with cancer stemness in kidney renal clear cell carcinoma.与肾透明细胞癌癌症干细胞特性相关的可变剪接。
BMC Cancer. 2021 Jun 15;21(1):703. doi: 10.1186/s12885-021-08470-8.
7
Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma.鉴定小分子药物并开发用于肾透明细胞癌的新型自噬相关预后标志物。
Cancer Med. 2020 Oct;9(19):7034-7051. doi: 10.1002/cam4.3367. Epub 2020 Aug 11.
8
Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma.肾透明细胞癌中两种新型预后长链非编码RNA的鉴定与验证
Cell Physiol Biochem. 2018;48(6):2549-2562. doi: 10.1159/000492699. Epub 2018 Aug 17.
9
Identification of novel prognostic alternative splicing signature in papillary renal cell carcinoma.乳头状肾细胞癌中新型预后性可变剪接特征的鉴定
J Cell Biochem. 2020 Jan;121(1):672-689. doi: 10.1002/jcb.29314. Epub 2019 Aug 12.
10
A seven-gene signature model predicts overall survival in kidney renal clear cell carcinoma.一个七基因签名模型预测肾透明细胞肾细胞癌的总生存期。
Hereditas. 2020 Sep 3;157(1):38. doi: 10.1186/s41065-020-00152-y.

引用本文的文献

1
Correlation study of LINC02609 and SNHG17 as prognostic biomarkers of kidney renal clear cell carcinoma and therapeutic sensitivity based on public data and analysis.基于公开数据和分析的LINC02609和SNHG17作为肾透明细胞癌预后生物标志物及治疗敏感性的相关性研究
Front Immunol. 2025 May 26;16:1592474. doi: 10.3389/fimmu.2025.1592474. eCollection 2025.
2
Inhibition of Aurora B kinase (AURKB) enhances the effectiveness of 5-fluorouracil chemotherapy against colorectal cancer cells.抑制 Aurora B 激酶(AURKB)可增强氟尿嘧啶化疗对结直肠癌细胞的疗效。
Br J Cancer. 2024 Apr;130(7):1196-1205. doi: 10.1038/s41416-024-02584-z. Epub 2024 Jan 29.
3

本文引用的文献

1
The Cancer Spliceome: Reprograming of Alternative Splicing in Cancer.癌症剪接体:癌症中可变剪接的重编程
Front Mol Biosci. 2018 Sep 7;5:80. doi: 10.3389/fmolb.2018.00080. eCollection 2018.
2
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
3
Cancer statistics, 2018.癌症统计数据,2018 年。
Identification of Key Prognostic Alternative Splicing Events of Costimulatory Molecule-Related Genes in Colon Cancer.
鉴定结肠癌中与共刺激分子相关基因的关键预后可变剪接事件。
Comb Chem High Throughput Screen. 2024;27(13):1900-1912. doi: 10.2174/0113862073249972231026060301.
4
Molecular Basis of Unequal Alternative Splicing of Human SCD5 and Its Alteration by Natural Genetic Variations.人类 SCD5 不等剪接的分子基础及其受天然遗传变异改变的情况。
Int J Mol Sci. 2023 Mar 30;24(7):6517. doi: 10.3390/ijms24076517.
5
SCD5 Regulation by VHL Affects Cell Proliferation and Lipid Homeostasis in ccRCC.VHL 对 SCD5 的调控影响 ccRCC 中的细胞增殖和脂质稳态。
Cells. 2023 Mar 8;12(6):835. doi: 10.3390/cells12060835.
6
Assessment of Diagnosis, Prognosis and Immune Infiltration Response to the Expression of the Ferroptosis-Related Molecule HAMP in Clear Cell Renal Cell Carcinoma.评估铁死亡相关分子 HAMP 在肾透明细胞癌中的表达对诊断、预后和免疫浸润反应的影响。
Int J Environ Res Public Health. 2023 Jan 4;20(2):913. doi: 10.3390/ijerph20020913.
7
A Novel m7G-Related Genes-Based Signature with Prognostic Value and Predictive Ability to Select Patients Responsive to Personalized Treatment Strategies in Bladder Cancer.一种基于新型m7G相关基因的特征,具有预后价值和预测能力,可用于选择对膀胱癌个性化治疗策略有反应的患者。
Cancers (Basel). 2022 Oct 29;14(21):5346. doi: 10.3390/cancers14215346.
8
Life Course Impact of Glucocorticoids During Pregnancy on Muscle Development and Function.孕期糖皮质激素对肌肉发育和功能的生命历程影响
Front Anim Sci. 2021;2. doi: 10.3389/fanim.2021.788930. Epub 2021 Dec 8.
9
Identification of subtypes of clear cell renal cell carcinoma and construction of a prognostic model based on fatty acid metabolism genes.透明细胞肾细胞癌亚型的鉴定及基于脂肪酸代谢基因的预后模型构建
Front Genet. 2022 Sep 16;13:1013178. doi: 10.3389/fgene.2022.1013178. eCollection 2022.
10
Establishment of a prognostic ferroptosis- and immune-related long noncoding RNAs profile in kidney renal clear cell carcinoma.肾透明细胞癌中预后性铁死亡和免疫相关长链非编码RNA特征的建立
Front Genet. 2022 Aug 30;13:915372. doi: 10.3389/fgene.2022.915372. eCollection 2022.
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
4
Revealing the Determinants of Widespread Alternative Splicing Perturbation in Cancer.揭示癌症中广泛的可变剪接扰动的决定因素。
Cell Rep. 2017 Oct 17;21(3):798-812. doi: 10.1016/j.celrep.2017.09.071.
5
Roles of alternative splicing in modulating transcriptional regulation.可变剪接在调控转录调控中的作用。
BMC Syst Biol. 2017 Oct 3;11(Suppl 5):89. doi: 10.1186/s12918-017-0465-6.
6
The role of RNA alternative splicing in regulating cancer metabolism.RNA可变剪接在调节癌症代谢中的作用。
Hum Genet. 2017 Sep;136(9):1113-1127. doi: 10.1007/s00439-017-1803-x. Epub 2017 Apr 20.
7
RNA splicing and splicing regulator changes in prostate cancer pathology.前列腺癌病理学中的RNA剪接及剪接调节因子变化
Hum Genet. 2017 Sep;136(9):1143-1154. doi: 10.1007/s00439-017-1792-9. Epub 2017 Apr 5.
8
Cysteine transporter SLC3A1 promotes breast cancer tumorigenesis.半胱氨酸转运蛋白SLC3A1促进乳腺癌的肿瘤发生。
Theranostics. 2017 Feb 26;7(4):1036-1046. doi: 10.7150/thno.18005. eCollection 2017.
9
A saga of cancer epigenetics: linking epigenetics to alternative splicing.癌症表观遗传学传奇:将表观遗传学与可变剪接联系起来
Biochem J. 2017 Mar 7;474(6):885-896. doi: 10.1042/BCJ20161047.
10
Identification of 42 Genes Linked to Stage II Colorectal Cancer Metastatic Relapse.与II期结直肠癌转移复发相关的42个基因的鉴定。
Int J Mol Sci. 2016 Apr 28;17(5):598. doi: 10.3390/ijms17050598.